MedPath

OVATION.IO, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Collection of Biological Specimens and Associated Health Information

Not yet recruiting
Conditions
Cancer
Other Disease
First Posted Date
2024-04-17
Last Posted Date
2024-04-17
Lead Sponsor
Ovation.io, Inc.
Target Recruit Count
10000
Registration Number
NCT06369441
Locations
🇺🇸

Ovation.io, Portland, Maine, United States

News

Illumina and Ovation.io Launch Groundbreaking GLP-1 Dataset to Transform Metabolic Disease Treatment

Illumina and Ovation.io are developing the largest commercial multiomic dataset from 25,000 patients treated with GLP-1 receptor agonists, integrating clinical, genomic, and proteomic data to advance drug development.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.